Evaluation of CAR-T cell cytotoxicity against a prostate carcinoma model
In recent years, a new promising application of adoptive cell therapy (ACT) has been enabled by the development of technologies and the successful clinical use of T cells with a chimeric antigen receptor (CAR-T) for treating patients with malignant B-cell neoplasms. In this study, we obtained CAR-T...
Main Authors: | A.Kh. Valiullina, E.A. Zmievskaya, A.R. Rakhmatullina, M.N. Zhuravleva, E.E. Garanina, R.R. Miftakhova, A.V. Petukhov, A.A. Rizvanov, E.R. Bulatov |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazan Federal University
2022-06-01
|
Series: | Učënye Zapiski Kazanskogo Universiteta. Seriâ Estestvennye Nauki |
Subjects: | |
Online Access: | https://kpfu.ru/uz-eng-ns-2022-2-3.html |
Similar Items
-
Knowns and Unknowns about CAR-T Cell Dysfunction
by: Aleksei Titov, et al.
Published: (2022-02-01) -
Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01) -
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
by: Aleksei Titov, et al.
Published: (2020-01-01) -
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
by: Ekaterina Zmievskaya, et al.
Published: (2021-01-01) -
Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
by: Aigul Kh. Valiullina, et al.
Published: (2023-02-01)